Navigation Links
Savient Provides Update on Pegloticase BLA
Date:2/12/2009

ged an experienced independent panel of clinical experts, headed by Dr. William B. White, Professor of Medicine, Calhoun Cardiology Center, University of Connecticut School of Medicine, to perform a formal blinded and unblinded post-hoc adjudication of all cardiovascular events included in reports of Serious Adverse Events, Infusion Reactions and Severe Infusion Reactions from the Phase 3 pegloticase trials. The primary event evaluation was predicated on the Anti-Platelet Trialist Collaborative (APTC) assessment criteria. This is a standardized approach that the FDA has widely accepted as a method of evaluating cardiovascular risk. APTC cardiovascular events include deaths, nonfatal myocardial infarction or nonfatal stroke. Dr. White and his panel concluded that:

  • As a result of the post-hoc blinded adjudication and unblinded review of the Serious Infusion reactions of the Phase 3 trials, there were 3 APTC cardiovascular events in the pegloticase treatment arms and 0 in the comparator placebo treatment arm. Furthermore, the panel found that there were 10 non-APTC cardiovascular events in the treatment arms and 0 non-APTC cardiovascular events in the comparator placebo treatment arm.

  • The panel also performed an un-blinded adjudication of the Company's Open Label Extension study employing the same criteria used for the Phase 3 trials with the exception that there were no patients on placebo during the Open Label Extension study. The panel found 2 APTC cardiovascular events and 7 non-APTC cardiovascular events. The data cut off date of this analysis was through August 29, 2008.

In addition to the work of Dr. White and his team, a separate external panel of experts performed an additional analysis by reviewing "all cause" mortality in the Phase 3 trials and Open Label Extension study. It is important to note that in the P
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. USAID Provides Malaria Assistance to Zimbabwe
3. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
4. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
5. American Dairy Provides Business Update
6. Alfacell Provides ONCONASE(R) NDA Submission Update
7. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
8. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
9. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
10. Raptor Pharmaceuticals Provides Update on Targeting Platforms
11. New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014 /PRNewswire-iReach/ -- CountryFocus: Healthcare, Regulatory ... (Photo - http://photos.prnewswire.com/prnh/20140828/140879 ) ... Regulatory and Reimbursement Landscape Poland " an essential ... in the healthcare market and provides insights into ... Most importantly, the report provides valuable insights into ...
(Date:8/28/2014)... Resources Group finds that the market for colorectal cancer (CRC) ... in the United States , ... Italy , Spain , the ... . The biosimilar erosion of Roche/Genentech/Chugai,s Avastin and Bristol-Myers Squibb/Eli ... of Eli Lilly,s Cyramza, Taiho Pharmaceutical,s Lonsurf, Alchemia,s HA-irinotecan and ...
(Date:8/28/2014)... CHARLOTTE, N.C. , Aug. 28, 2014 /PRNewswire/ ... innovation marketplace, today announced a worldwide search for ... of the senior population.  Promising ideas uncovered through ... presented to leading medical device manufacturers and healthcare ... to improve the lives of individuals age 65 ...
Breaking Medicine Technology:Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3
... ... , ... , , , ... ...
... , ... ... ... ...
Cached Medicine Technology:Smith & Nephew Orthopaedics Launches Versatile VLP(TM) FOOT Plating System 2Smith & Nephew Orthopaedics Launches Versatile VLP(TM) FOOT Plating System 3Smith & Nephew Orthopaedics Launches Versatile VLP(TM) FOOT Plating System 4Smith & Nephew Orthopaedics Launches Versatile VLP(TM) FOOT Plating System 5An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists 2An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists 3An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists 4An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists 5An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists 6
(Date:8/28/2014)... Fifty percent of adults who seek ... twenty percent of Americans claim to have fatigue that ... Adrenal Fatigue is the most common yet overlooked cause ... classic symptoms. Tasks that were once a breeze are ... didn’t cause irritation, experiencing weight gain around the middle ...
(Date:8/28/2014)... Doctors Frank DellaCroce and Scott Sullivan, ... (CRBS) and the St. Charles Surgical Hospital ... that board certified surgeon Dr. Craig Ashley Blum has ... to reconstructive breast surgery. Blum will work with the ... Trahan, and M. Whitten Wise. , “We are excited ...
(Date:8/28/2014)... August 29, 2014 Involution ... some of the healthcare industry's most pressing problems, ... radically rethink health. Involution Studios' creative team ... creating software solutions for clients including AstraZeneca, 3M ... As part of the studio's philosophy to change ...
(Date:8/28/2014)... Starting on Monday, the Mesothelioma Applied ... in Bitcoin, in addition to all the traditional ways ... at http://www.curemeso.org/bitcoin . , “As more and ... payment, we decided it was important for us to ... Melinda Kotzian. , Bitcoin is an online-only, internet ...
(Date:8/28/2014)... Skmen.com, one of the most popular suppliers of men’s ... long sleeve sweater dresses and launched a ... unveiled sweater outfits are available at discounted rates, up ... of fact, Skmen.com’s fashionable and quality items have greatly ... company’s experienced tailors are striving to make more incomparable ...
Breaking Medicine News(10 mins):Health News:Peoria AlignLife Clinics Focus on Community Education 2Health News:New Plastic Surgeon Joins Center For Restorative Breast Surgery 2Health News:Top Three Open Source Design Concepts that Rethink Health from Involution Studios 2Health News:Top Three Open Source Design Concepts that Rethink Health from Involution Studios 3Health News:Cancer Research Funding Organization Now Accepts Bitcoin Donations 2Health News:Skmen.com: Bestselling Long Sleeve Sweater Dresses Are Offered Online Now 2
... Findings suggest airway pressure treatment prevents complications, cuts readmissions ... hours of postoperative treatment with continuous positive airway pressure ... heart surgery, finds a new study. , CPAP is ... study, published in the May issue of Chest ...
... discovered gene known as DEAR1 is mutated in breast cancer ... early-onset breast cancer, a research team headed by scientists at ... in the journal PLoS Medicine . , "The ... women have recurrences in the breast, and cancers that do ...
... $1.5 Million - $3 MillionPRINCETON, N.J., May 6 ... DSCI), a manufacturer and marketer of advanced wound care products, ... private label adhesive bandages to one of the largest medical ... are expected to range between $1.5 to $3.0 million for ...
... conference focused on promoting physical activity on college ... on connecting health care providers and the public ... infiltrating college campuses nationwide. The American College of ... On Campus," a program component to address and ...
... --Leadership in Fight Against Tobacco Recognized Nationally--WASHINGTON, May ... has been named the South Regional Youth Advocate ... Kids for her leadership in the fight against ... in the nation,s capital tonight (May 6) along ...
... has potent anti-inflammatory properties and British scientists have now found that ... substance feared in biologic warfare. , ... Manhasset, NY ... British scientists have now found that it is helpful in delaying ...
Cached Medicine News:Health News:Novel gene predicts local recurrence in early onset breast cancer 2Health News:Novel gene predicts local recurrence in early onset breast cancer 3Health News:Derma Sciences Announces New Contract With Major Medical Products Supplier for Private Label Adhesive Bandages 2Health News:Derma Sciences Announces New Contract With Major Medical Products Supplier for Private Label Adhesive Bandages 3Health News:'Exercise is Medicine On Campus' Launches With National Call to Action 2Health News:'Exercise is Medicine On Campus' Launches With National Call to Action 3Health News:Campaign for Tobacco-Free Kids Honors Colleen Daly of Asheville, NC As Youth Advocate of the Year 2Health News:Nicotine May Help Prevent Damage from Bioterrosim Toxin and Growth Factors in Heart Disease News from Molecular Medicine 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: